Articles

Many patients and their loved ones find it difficult to discuss end-of-life care with physicians. Read More ›

A new study shows that chemotherapy can induce changes in the brain that may affect concentration and memory. Read More ›

Researchers recently assessed the impact of the 2009 revised guidelines for screening mammography issued by the US Preventive Services Task Force (USPSTF). Read More ›

Interest in pancreatic neuroendocrine tumors (pNETs) has grown since the recent approval of targeted agents for advanced disease, as was evident by the attendance at several sessions during the European Society for Medical Oncology (ESMO) 2012 Congress in Vienna, Austria.¹ Read More ›

In 2012, approximately 1.6 million new cases of cancer will be diagnosed in the United States.¹ A family caregiver, or informal caregiver, will become a necessity for many of the newly diagnosed patients. A family caregiver provides emotional, physical, psychological, and spiritual support to the patient. This, in turn, can take a toll on a caregiver’s own physical, emotional, and even financial health as well. The following statistics provide a glimpse into the characteristics of these unique care providers. Read More ›

According to a study from the US Oncology Network, breast cancer patients treated with adjuvant chemotherapy have no increased risk for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), at least within the first 3 years of treatment. The study was presented at the American Society of Clinical Oncology 2012 Breast Cancer Symposium by Neelima Denduluri, MD, of Virginia Cancer Specialists.¹ Read More ›

A common and potentially long-lasting side effect of cancer and cancer treatment, fatigue may last for months or years. Read More ›

Cancer-fighting foods are abundant during autumn. Read More ›

Beyond size, the quality of personal relationships is also important to survival in patients with breast cancer. Read More ›

Risk of heart failure is even greater for those patients treated with adjuvant trastuzumab. Read More ›